Fast Five Quiz: Relapsing-Remitting Multiple Sclerosis Management

Christopher Luzzio, MD; Kerstin Hellwig, MD

Disclosures

June 30, 2022

Routes by which drugs for RRMS are administered are:

Oral: fingolimod, siponimod, cladribine, diroximel fumarate, ozanimod, teriflunomide, dimethyl fumarate, monomethyl fumarate
Intravenous: ocrelizumab, natalizumab, mitoxantrone
Intramuscular: Interferon beta-1a
Subcutaneous: Interferon beta-1a, Interferon beta-1b, glatiramer acetate

Learn more about the diagnosis and management strategies of MS.

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Christopher Luzzio, Kerstin Hellwig. Fast Five Quiz: Relapsing-Remitting Multiple Sclerosis Management - Medscape - Jun 30, 2022.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.